Challenging the Medicalization of Sex




Click to learn more and to purchase this and other books.

NVC in the Press - 2015

Select a year:

Title: FDA approval of flibanserin
Date: 12/11/2015
Description: Defense by FDA team of its approval of flibanserin after 2 rejections. Acknowledges misleading role of "Even the Score" campaign but insists it had no influence over the scientific decision. 4 pages worth saving.
Author: Hylton V. Joffe and 10 others
Source: New England Journal of Medicine
URL: visit link

Title: Sprout CEO Cindy Whitehead leaves company
Date: 12/9/2015
Description: Addyi selling badly. Sprout Pharma new owner Valeant in midst of scandals over drug pricing. So, Cindy Whitehead takes her $1B and leaves the ship.
Author: David Bracken
Source: News Observer (North Carolina)
URL: visit link

Title: Valeants newest problem: The female libido pill isnt selling
Date: 11/17/2015
Description: Sales extremely weak for Addyi in first month: 227 vs. tens of thousands for Viagra in same period in 1998. Seems the info about side effects, lack of efficacy and daily administration have gotten through to the public.
Author: Anna Edney and Laura Colby
Source: The Globe and Mail (Canada)
URL: visit link

Title: Is the Female Viagra Worth It?
Date: 11/10/2015
Description: Thorough and critical piece, emphasizing how high placebo rates often indicate the power of nonmedical effects and also emphasizing responsive versus spontaneous desire. Goes into the dirty underbelly of drug pricing and how Valeant will probably jack up the price [which it did!].
Author: Beth Skwarecki
URL: visit link

Title: It'll Take More Than Meds To Boost Women's Sex Drives
Date: 10/20/2015
Description: Vienna study on oxytocin produced unexpected result. Required to collaborate with partner on feedback, both drug and placebo subjects improved equally in sexual satisfaction. Goes to show how important it is to change the pharma clinical trials research methods.
Author: Alex Zielinski
Source: Think Progress
URL: visit link

Title: 'Female Viagra' Is Here, But Don't Go Running to Your Doctor
Date: 10/19/2015
Description: Short critical piece with good links to the various issues. Good to see in a major mass outlet.
Author: Susan Rinkunas
Source: The Cut (New York Magazine Online)
URL: visit link

Title: A Female Sex Pill is Getting Women's Attention, But This Side Effect Might Not Be So Thrilling
Date: 10/18/2015
Description: Ordinary piece with 2 opposing quotes that are very useful: Susan Wood (former FDA, Office of Women's Health) says "neither very effective nor particularly safe," vs. Lauren Streicher (Northwestern U gynecologist) says, "this is going to be a game changer for me because right now I have women that come into my office and have these issues and I just say, 'I'm so sorry. There is nothing that I can do.'"
Author: Lawrence Bonk
Source: Independent Journal Review
URL: visit link

Title: The 'female Viagra' goes on sale today, though fears persist about its dangers
Date: 10/17/2015
Description: Overview emphasizing Irwin Goldstein's links to pharma and Sprout.
Author: Patrick Kulp
Source: Mashable
URL: visit link

Title: The first 'female Viagra' is here. Who wants it?
Date: 10/15/2015
Description: Lengthy cover story for Wash Post magazine comes out the weekend Addyi is available, but the focus is on a woman with post- ovariectomy loss of desire treated with HRT. Nothing about history, politics, dilemmas of Addyi or eventhescore.
Author: Brigid Schulte
Source: Washington Post magazine (cover)
URL: visit link

Title: Addyi: Not the Women's Sex Pill You've Been Waiting For
Date: 10/14/2015
Description: Good overview, and focusing on "Even the Score" asks, "Did the strategy corrupt the approval process?" Calls out its "shady past" and "marginal benefit."
Author: Sally Chew
Source: AlterNet
URL: visit link

Title: Stephen Colbert Has a Few Thoughts on the New "Female Viagra" [VIDEO]
Date: 9/19/2015
Description: Commentary and video of 4 minutes of Stephen Colbert satire on flibanserin, Sprout, Addyi, HSDD, and the insanity of developing a drug for romance that prohibits alcohol indefinitely. He definitely says the emperor is naked - Go, Steve! It's the latest lecture in the science of bonerology.
Author: Sharan Shetty
Source: Slate
URL: visit link

Title: What the FDA's approval of "pink Viagra" tells us about the problems with drug regulation
Date: 9/18/2015
Description: Reviews changes over the last decades in FDA standards for approval. Concludes that 5-year review of PDUFA (law that requires drug companies pay the FDA to get into drug approval process) has created loopholes. 2007 introduced REMS allowing FDA to approve riskier drugs as long as certain precautions are used. Approval of flibanserin not just due to "Even the Score," but regulation problems.
Author: Julia Belluz
Source: Vox
URL: visit link

Title: On the eve of its release, question remains: is pink Viagra solving a problem that does not exist? [VIDEO]
Date: 9/18/2015
Description: Interview (video) with Thea Cacchioni on "Big Pharma, Women, and the Labour of Love" and Addyi. She predicts poor use and satisfaction with the drug based on her research with women having sex in their real interpersonal context.
Author: Sharon Kirkey
Source: National Post (Canada)
URL: visit link

Title: Female Libido Pill Caused Dissent in FDA Ranks, Memo Shows
Date: 9/17/2015
Description: Disagreements among FDA regulators shown in lengthy FDA summary report da_ docs/nda/2015/022526Orig1s000SumR. pdf. Contact Bloomberg News for full access.
Author: Anna Edney
Source: Bloomberg News
URL: visit link

Title: Pleasure in a Pill?
Date: 9/16/2015
Description: Lengthy magazine article about FSD featuring patients who love their drugs but also covers "Even the Score" campaign, the FDA hearing, and NVC critical voices.
Author: Virginia Sole-Smith
Source: Marie Claire magazine
URL: visit link

Title: The Disordered Logic of Female Sexual Interest/Arousal Disorder
Date: 9/8/2015
Description: Australian feminist bioethicist Tamara Browne weighs in whether FSIAD can be considered a disorder, when there is no normal level of desire and the condition is about distress. "Interpersonal or social persecution" may be at the heart.
Author: Tamara Kayali Browne
Source: Impact Ethics blog
URL: visit link

Title: FDA Approves Addyi, Rejects Gender Discrimination Claims
Date: 9/7/2015
Description: Short Pharma press article on FDA's Dr. Hylton Joffe's memo explaining the Addyi decision and acknowledging the political controversy. Useful to cite and link to FDA summary report. Contact Pharma Intelligence for full article.
Author: Michael McCaughan
Source: Pharma Intelligence
URL: visit link

Title: 'Female Viagra' has Indian men in thrall: Doctors
Date: 9/4/2015
Description: Dr. Prokash Kothari, the "Dr. Ruth of India," has been getting lots of inquiries about flibanserin from men! Why? Chennai sexologist says it's because men are "lazy." Kothari tells case where wife's low desire is due to husband's tobacco smell and no foreplay. He says he has seen "50,000" cases of low desire in women and flibanserin won't work in them. Instead they must work on OCD, depression, anxiety, or organ trouble.
Author: Pratiksha Ramkumar
Source: Times of India
URL: visit link

Title: Does 'female Viagra' pathologize asexuality?
Date: 9/4/2015
Description: Links to important pieces on flibanserin and asexuality. A growing critical voice.
Author: Brandon Baker
Source: Philly Voice (local paper)
URL: visit link

Title: With flibanserin approval, a complicated drug takes the spotlight
Date: 9/3/2015
Description: Thorough review including critique from Adriane Fugh-Berman and Ob-Gyn John Thorp. Also fantasy neuroscience from ObGyn Judith Volkar. Strong conclusion says "the hope of further investment seems a poor reason to approve a drug with such minor improvements and major expectations"
Author: Bethany Brookshire
Source: Science News
URL: visit link

Title: Sex, Drugs, and Women's Desire
Date: 9/3/2015
Description: Critical analysis focuses on Barbara Gattuso, Goldstein patient, who gets aroused but wants "desire." Had "problem" for 20 years, never told husband. Goldstein filmed her after B-I trial ended and took film to Cindy Whitehead (CEO) to get Sprout Pharma involved. Other interesting details and an analysis of responsive desire from Emily Nagoski of NVC.
Author: Anna Nowogrodzki
Source: PBS Nova Next
URL: visit link

Title: Flibanserin (Addyi), the Alleged Libido Pill For Women What Women Need to Know Before Asking for it
Date: 9/3/2015
Description: His own perspective. Drug will be expensive, will destroy serotonin nerves, and will not reverse drug-caused sexual dysfunction. Emphasizes interactions and SSRI-induced dysfunctions.
Author: Gary Kohls, MD
Source: Center for Research on Globalization
URL: visit link

Title: The Controversial Doctor Behind the New "Viagra for Women"
Date: 9/2/2015
Description: Background on Irwin Goldstein and role in creating FSD and pushing drugs and diagnoses since 1998. Links to journalism and social science. Recalls pushing "androgen deficiency syndrome" in 2002 as Intrinsa is on deck. Brought video of patient to Cindy Whitehead (Sprout Pharma CEO) in 2010 to persuade her to take on flibanserin.
Author: Molly Redden
Source: Mother Jones
URL: visit link

Title: We don't need female Viagra, we need feminism
Date: 9/1/2015
Description: "That feminism is now an approved marketing strategy shows us how powerful and culturally important the movement is. All the same, this is nothing to celebrate... feminism must not be co-opted by companies whose ultimate agenda is not women’s welfare but their own bottom line. Feminism is about putting more power in the hands of women, not putting more profit in the pockets of drug and cosmetics companies. Feminist liberation is not, ultimately, something you can buy. "
Author: Laurie Penny
Source: New Statesman
URL: visit link

Title: Flibanserin and Feminism
Date: 8/31/2015
Description: "Flibanserin isn't female Viagra. Lubricant is female Viagra." "Sprout’s campaign was profoundly sexist." Flibanserin approved by misleading PR campaign. All Sprout is men; There is no normal level of libido.
Author: Adriane Fugh-Berman & Alessandra Hirsch
Source: Impact Ethics (blog)
URL: visit link

Title: How Medscape helped Sprout stack the deck for Addyi
Date: 8/29/2015
Description: Reviews Journal of Medical Ethics article 06/28/medethics-2014-102596.short? rss=1 by Fugh-Berman. "The tactic of getting doctors to buy into the medicalization of normal via industry funded CME is effective." Excellent presentation with pictures from the Medscape CME courses.
Author: Jen Gunter
Source: Dr. Jen Gunter's blog
URL: visit link

Title: The Female Sex Pill [VIDEO]
Date: 8/28/2015
Description: Five minute segment on flibanserin that is comical and trenchant. Pillify the drug to take to make you want to take a drug you need to take to do something you don't want to do. Further, Maher argues that if Caitlyn Jenner can be the kind of sexual person she wants to be, why can't women with low desire be the kind of sexual person they are, too, without stigma and interference!
Author: Bill Maher
Source: Real Time with Bill Maher
URL: visit link

Title: Broad Questions [AUDIO]
Date: 8/28/2015
Description: Second half hour of this show devoted to THOROUGH examination of flibanserin story. Lori Brotto, Susan Wood, and Thea Cacchioni speak important truths about "Even the Score" to counter misinformation and official rhetoric from Sprout et al. as presented by Sally Greenberg and Sheryl Kinsgberg.
Author: Brooke Gladstone, host
Source: WNYC "On The Media" Radio Program
URL: visit link

Title: Opinion: A new sex drug for women - Don't be seduced by the hype
Date: 8/27/2015
Description: Montreal doctor says, "And so we have a drug that doesnt really work, with serious side effects, to treat a condition that doesnt really exist, that was approved not because of science, but because of a media campaign." Great quote.
Author: Christopher Labos
Source: Montreal Gazette opinion
URL: visit link

Title: Addyi Alcohol Safety Was Tested Mostly on Men
Date: 8/25/2015
Description: First close examination of feeble alcohol challenge study on flibanserin Sprout gave to the FDA. Now Addyi has a black box warning, but we still lack the accurate information about alochol-drug interactions. This could be the Achilles' heel.
Author: Melissa Dahl
Source: New York Magazine: Science of Us
URL: visit link

Title: What Do the Data Show About Addyi? [Video]
Date: 8/25/2015
Description: 7-minute video analysis of the data. Very even-handed. Concludes harms not worth benefits.
Author: Perry Wilson, MD
Source: MedPage Today (GYN)
URL: visit link

Title: Flibanserin, 'female Viagra,' distracts from real causes of low libido: critics
Date: 8/24/2015
Description: Cynthia Graham and Leonore Tiefer offer long ideas about sexual desire and why a pill won't work. Unrealistic expectations, looking for excuses in biology, changes in DSM nomenclature.
Author: Kazi Stastna
Source: CBC News
URL: visit link

Title: OK for female sex drug follows patient-centered trend
Date: 8/23/2015
Description: Shows how recent trends favor patient involvement in drug approval. REMS approved in 2007. Gives other examples of grassroots groups, e.g. "Be Reasonable" campaign for muscular dystrophy. Peter Pitts, former FDA official, lists problems with "ginning up anger."
Author: Robert King
Source: Washington Examiner
URL: visit link

Title: The new female libido drug may not be the feminist victory that it seems
Date: 8/20/2015
Description: Short piece emphasizing benefits are small, nothing like Viagra, the price may be high, can't use with alcohol. First piece to mention price!
Author: Carolyn Y. Johnson
Source: Washington Post (Wonkblog)
URL: visit link

Title: The Misinformation Behind Female Viagra with Dr. Leonore Tiefer [VIDEO]
Date: 8/20/2015
Description: Nine minute television interview with Leonore Tiefer. Excellent opportunity to critique diagnoses, "Even the Score," drug safety and effectiveness.
Source: Watching the Hawks TV News program
URL: visit link

Title: Valeant to buy female libido drugmaker Sprout for $1 billion [VIDEO]
Date: 8/20/2015
Description: Five minute TV interview with Valeant CEO and Sprout CEO Whitehead about plans for Addyi profit, marketing, advertising, pricing. Valeant expecting "billions."
Author: Christine Seib and Tom DiChristopher
Source: CNBC
URL: visit link

Title: From 1952-2015: The path to 'Female Viagra' has been a rocky one - but the 'Female Viagra' could get FDA approval this week
Date: 8/18/2015
Description: Chronology of medical and pharmaceutical efforts from DSM-I in 1952 to Advisory Committee hearing in July, 2015. A lot of research went into this!!
Author: Brigid Schulte
Source: Washington Post
URL: visit link

Title: How Big Pharma Used Feminism To Get The "Female Viagra" Approved
Date: 8/18/2015
Description: Analysis of the playbook of "Even the Score." Very useful and strong critical perspective.
Author: Azeen Ghorayshi
Source: Buzzfeed
URL: visit link

Title: Flibanserin: The Female Viagra is a Failed Me-too Antidepressant
Date: 8/17/2015
Description: Analyzes "institutional corruption" at the heart of the flibanserin/eventhescore campaign. Legal, but unethical influences. Trials show statistical but not meaningful effects. Slippery targeted indication (HSDD). COI in developing measures.
Author: Emily Wheeler, Madeline Brodt, Shannon Peters, and Lisa Cosgrove.
Source: Mad in America blog
URL: visit link

Title: 'I Want To Want To Have Sex'
Date: 8/17/2015
Description: Journalist looks for women with low desire problems to profile. She interviews the familiar suspects who have made the pro-flibanserin rounds for months (aren't we tired of them and their practiced one- liners?) but also finds some anti-drug women whose stories are quite different.
Author: Amy Nordrum
Source: International Business Times
URL: visit link

Title: Raleigh's Sprout Pharmaceuticals awaits FDA ruling on female libido drug
Date: 8/15/2015
Description: Sprout plans to quadruple its employees, charge $30-$75/mo above insurance, open plants in Virginia and Georgia and go for a $2B/yr market. Gyn John Thorp at UNC offers some critical views.
Author: John Murawski
Source: Charlotte Observer
URL: visit link

Title: Drug executives seeking approval for female libido pill previously ran afoul of FDA rules
Date: 8/14/2015
Description: Reports story of Sprout executives' previous history with SLATE Pharma, manufacturer of Testopel, in 2010. 10 page letter from FDA detailing unethical marketing practices. Big boosters of testosterone for everything!
Author: Matthew Perrone
Source: The Toronto Star
URL: visit link

Title: What Big Pharma Doesn't Want You To Know About 'Female Viagra'
Date: 8/14/2015
Description: Nine minute video by Center for American Progress. Great research - FDA list of actual drugs available for sexual problems, false information by Sprout and "Even the Score, Cindy Pearson of National Women’s Health Network gives the critique very powerfully.
Author: Igor Volsky & Victoria Fleischer
URL: visit link

Title: Women's sex drug gets political hard sell
Date: 8/13/2015
Description: Emphasis on the eventhescore politicking. Criticism from Susan Wood, follow the Sprout money to NCL and SWHR, and mention of the "intimidating" environment according to urologist Hanno at the advisory hearing.
Author: Sarah Karlin
Source: Politico
URL: visit link

Title: Drugmaker, Women Waiting for Female Sex-Drug
Date: 8/12/2015
Description: 2 minute video from Associated Press that gives a snippet of our song, but mostly emphasizes the hard-working little start-up, Sprout. Well, the reporter is based in Raleigh, NC, after all...
Author: Allen Breed
Source: Associated Press
URL: visit link

Title: 'Female Viagra' Foes Denounce PR Campaign to Win FDA Approval
Date: 8/10/2015
Description: Thorough Medscape overview of letters to FDA from New View and PharmedOut along with Sprout 'answers' to accusations. Must contact Medscape for full access.
Author: Robert Lowes
Source: Medscape
URL: visit link

Title: Let's Stop Calling It 'Female Viagra,' Okay?
Date: 8/3/2015
Description: Critical piece based on and embedding Aaron Carroll's blog that reviews the many differences between flibanserin and Viagra.
Author: Melissa Dahl
Source: New York Magazine
URL: visit link

Title: [VIDEO] What is Flibanserin (AKA "Female Viagra")?
Date: 7/27/2015
Description: 7 minute very thorough and comprehensive video about flibanserin by a pharma-savvy pediatrician. Devastating!
Author: Aaron Carroll MD
Source: The Incidental economist Blog
URL: visit link

Title: [AUDIO] BBC Radio Interviews on "Low Libido"
Date: 7/14/2015
Description: The part of this radio show on HSDD and flibanserin is from 09:18 to 21:40. Interviewed are Petra Boynton from UK and Ray Moynhian from Australia. Very powerful focus on creation of diagnosis by marketers.
Source: "Inside Health" (Hourlong show - most on HSDD and flibanserin)
URL: visit link

Title: Female Viagra a political tightrope for FDA, advisors warn
Date: 7/6/2015
Description: Melissa Healy reports on the editorial just published in JAMA by 3 members of the flibanserin Advisory Committee and points out this means trouble for the drug's final approval.
Author: Melissa Healy
Source: L. A. Times
URL: visit link

Title: Evaluation of Flibanserin: Science and Advocacy at the FDA
Date: 7/6/2015
Description: Comprehensive editorial by 3 members of the June 4 Advisory Committee for flibanserin. They review all the negatives - "Even the Score," shifting end points, limited efficacy, many side effects and complications - sounds like thumbs down. Contact JAMA for full text.
Author: Gellad, WF, Flynn, KE, & Alexander, GC
Source: JAMA
URL: visit link

Title: US FDA set to approve flibanserin, the female Viagra
Date: 7/4/2015
Description: Crusading investigative journalist Ray Moynihan knocks the wind out of flibanserin's sails with his critical overview of the politics, the lack of effectiveness, the harms, the whole enchilada!
Author: Ray Moynihan
Source: The Saturday Paper (Australia)
URL: visit link

Title: Many women reject female 'Viagra' pill
Date: 6/29/2015
Description: Interesting UK survey shows most women would not take flibanerin especially after learning it has to be taken chronically.
Author: UK Medix survey
Source: Health24
URL: visit link

Title: FDA advisors urge physician certification for flibanserin
Date: 6/23/2015
Description: Psychiatry newsletter emphasizes burdens of Risk Evaluation Mitigation Strategy that will come with flibanserin approval, especially the likelihood of "physician certification." This will be too high a bar for many busy doctors.
Author: Elizabeth Mechcatie
Source: Clinical Psychiatry News
URL: visit link

Title: Does the female Viagra really work?
Date: 6/22/2015
Description: Here is a really good, thorough and critical article from the UK Daily Mail that hits all the high points about medicalization, poor efficacy, side effects, false idea of normal libido, will be overprescribed and overmarketed.
Author: John Naish
Source: UK Daily Mail
URL: visit link

Title: "Arousal first!" desire may be more typical for women and it doesn't need a cure
Date: 6/21/2015
Description: Very important lengthy piece featuring arguments for Responsive desire ("Arousal first!") rather than Spontaneous desire being the norm. Many quotes from New Viewers.
Author: Zosia Bielski
Source: The Globe and Mail (Canada)
URL: visit link

Title: There's a female sex pill? Give me a loaded dishwasher any day
Date: 6/20/2015
Description: Tongue in cheek - or maybe not - argument that desire comes from husbands doing housework. UK author Susan Maushart of book called Wifework cited.
Author: Victoria White
Source: Herald (Ireland)
URL: visit link

Title: Is the multi-million dollar campaign for a female viagra just pink wash?
Date: 6/20/2015
Description: Australian sexologists such as Juliet Richters weigh in with criticism about flibanserin.
Author: Nicky Phillips
Source: Sydney Morning Herald (Australia)
URL: visit link

Title: [AUDIO] Exploring "female Viagra," women's libidos and sexual dysfunction
Date: 6/17/2015
Description: 50 minutes of terrific and thorough interviewing by expert host Marty Moss- Coane about flibanserin. History of drugs for women, harms, efficacy, theories of sexual desire, questions about Sprout Pharma - the whole enchilada!!
Author: Thea Cacchioni, Meredith Chivers and Debby Herbenick
Source: WHYY (NPR Radio in Philadelphia)
URL: visit link

Title: A pill to control female desire? Dream on.
Date: 6/15/2015
Description: It's not women's desire that needs fixing but society's idea of what's normal.
Author: Jennifer O'Connell
Source: Irish Times
URL: visit link

Title: Sex, drugs and confusion
Date: 6/15/2015
Description: Analysis of an Australian TV doctor whose facts about flibanserin were all wrong. I'ts the same as Viagra; there are no side effects, etc. Is this what the publicity will be like?
Source: Media Watch on Australian TV
URL: visit link

Title: Bad Sexual Chemistry: Female viagra is a flawed idea
Date: 6/15/2015
Description: Reviews side effects, miniscule effectiveness, and differences from Viagra and quotes Adriane Fugh-Berman's testimony.
Author: Suzanne Harrington
Source: Irish Examiner
URL: visit link

Title: Politics of Pleasure
Date: 6/14/2015
Description: In the Indian context. This short analysis touches on issues of pleasure that seem completely overlooked by the US press coverage of the flibanserin approval.
Author: Jolene Gupta
Source: DNAIndia
URL: visit link

Title: Aid to Women, or Bottom Line? Advocates Split on Libido Pill
Date: 6/13/2015
Description: Front page New York Times article exposes further links between "Even the Score," Sprout Pharma, and the flibanserin hearings. It's very important to see this attention paid to the improper politics.
Author: Sabrina Tavernise and Andrew Pollack
Source: New York Times
URL: visit link

Title: Is Female Viagra Really as Great as it Sounds?
Date: 6/12/2015
Description: Good overview with strong critical voices.
Author: Julia Robins
Source: MS. Magazine
URL: visit link

Title: A Pill to Boost Female Libido
Date: 6/12/2015
Description: Balanced overview - not critical enough although all the points are there. Concluding sentence: The F.D.A. should only approve the drug if strong measures are taken to reduce safety concerns.
Author: Editorial
Source: New York Times
URL: visit link

Title: Susie Essman slams flibanserin [VIDEO]
Date: 6/11/2015
Description: On The Nightly Show American comedian Susie Essman brilliantly decks flibanserin in a 3 minute rant.
Source: Comedy Central
URL: visit link

Title: FDA Approves Female-Libido-Enhancing Man
Date: 6/9/2015
Description: A satire about what women really need. SEXUAL STIMULATION. A little heterosexist, but everyone will get the point. I love it that the FDA is approving this desire enhancer!
URL: visit link

Title: "Pink Viagra": Clever media campaign, marginal drug
Date: 6/8/2015
Description: Thoughtful concise critique. Concludes, "A magic pill may some day come, but its name is not flibanserin. For women in search of desire, a mediocre drug with a poor safety profile is not a solution, its another problem."
Author: Andre Picard
Source: Globe and Mail (Canada)
URL: visit link

Title: Love, Sex, and Pink Viagra
Date: 6/8/2015
Description: Critical Piece - links to Guardian Op-Ed. Nursing Clio is an open access, peer- reviewed, collaborative blog project that ties historical scholarship to present-day issues related to gender and medicine. Author is gender studies professor.
Author: Elizabeth Reis
Source: Nursing Clio
URL: visit link

Title: A 'Female Viagra' And Female Sexuality [AUDIO]
Date: 6/8/2015
Description: NPR national call-in radio show, On Point Leonore Tiefer with pro-drug Lauren Streicher Chicago Ob-Gyn, plus Terry O'Neill from NOW. It was a hot and heavy debate.
Author: National Public Radio
Source: WBUR
URL: visit link

Title: I'm a feminist. Here's why I don't support the "female Viagra".
Date: 6/8/2015
Description: Executive Director of National Women's Health Network explains why flibanserin's approval is not a benefit for women
Author: Cindy Pearson
Source: Washington Post
URL: visit link

Title: [AUDIO] Risks And Benefits Of So-Called Viagra-For-Women
Date: 6/8/2015
Description: Debate among Emily Nagoski, Adriane Fugh-Berman, James Simon, Jennifer Berman. Strikingly different perspectives. Adriane says, boldly, HSDD was created to sell drugs - go Adriane!!
Author: Nagoski, Fugh-Berman etc.
Source: Diane Rehm Radio Show
URL: visit link

Title: Critics: Women's Sex Pill Approval Vote Driven By PR, Not Science
Date: 6/7/2015
Description: Thorough critique including powerful quotes from Susan Wood, former head of the FDA Office of Women's Health, who resigned in 2005 over the Plan B fiasco.
Author: David Kroll
Source: Forbes
URL: visit link

Title: Flibanserin Is Being Dubbed the Female Viagra, but Is It Really?
Date: 6/7/2015
Description: Journalist picks up on critiques from June 6
Author: Heather Granruth
Source: Guardian (UK) Liberty Voice
URL: visit link

Title: A sexually satisfying event for women, or just a new identity for an old antidepressant?
Date: 6/6/2015
Description: Succinct critique by the director of the Australian Research Centre in Sex, Health and Society at La Trobe University.
Author: Jayne Lucke
Source: The Conversation
URL: visit link

Title: Stop Calling Flibanserin "Female Viagra"
Date: 6/5/2015
Description: Shows why it's a basic misunderstanding to call flibanserin pink Viagra.
Author: Helen Thompson
Source: Smithsonian
URL: visit link

Title: Is "Female Viagra" What Women Want? [AUDIO]
Date: 6/5/2015
Description: Live studio interview of Leonore Tiefer on Brian Lehrer WNYC New York (NPR radio). The day after the FDA vote.
Author: Brian Lehrer, Leonore Tiefer
Source: WNYC Radio Interview
URL: visit link

Title: Flibanserin sparks debate about women and sexuality
Date: 6/5/2015
Description: Only press piece to take on issue of spontaneous vs responsive desire. Thoughtful and useful.
Author: Tracy Clark-Flory
URL: visit link

Title: Op-Ed: We shouldn't push dubious 'pink Viagra' pills on women and call it emancipation
Date: 6/5/2015
Description: Guardian following FDA vote on flibanserin
Author: Barbara Mintzes and Leonore Tiefer
Source: The Guardian US
URL: visit link

Title: Female Viagra FDA Approval: 5 Facts Women Should Know About Flibanserin
Date: 6/5/2015
Description: Thoughtful coverage of flibanserin vs. Viagra information. Only coverage to identify study population as being married average of 10 years. (And still being premenopausal.)
Author: Amy Nordrum
Source: International Business Times
URL: visit link

Title: Astroturfers rule the day: FDAs flibanserin reviewers were "emotionally blackmailed" by a slick lobbying campaign
Date: 6/5/2015
Description: Blog by crusading Canadian journalist. Probably the only piece covering the flibanserin hearing that will use the term astroturf. VERY powerful.
Author: Alan Cassels
Source: Health News Review
URL: visit link

Title: "Viagra for women" wins FDA approval with strings attached
Date: 6/4/2015
Description: Widely read newspaper emphasizes approval WITH STRINGS ATTACHED and mentions need for special certification for doctors and pharmacists.
Author: Ben Mitchell
Source: USA Today
URL: visit link

Title: FDA backing of 'Viagra' for women pill draws concern from critics
Date: 6/4/2015
Description: Quotes at length from Canadian critics including Lori Brotto, Thea Cacchioni, and David Mackenzie.
Author: Wendy Stueck
Source: The Globe and Mail (Canada)
URL: visit link

Title: "Viagra for Women" Gets Push for F.D.A. Approval
Date: 5/31/2015
Description: Thorough examination of issues at stake in upcoming flibanserin hearing June 4 2015. Discloses questionable practices by Sprout Pharma. Quotes from Thea Cacchioni and Leonore Tiefer.
Author: Andrew Pollack
Source: New York Times
URL: visit link

Title: Will Female Viagra be an FDA Boner?
Date: 5/28/2015
Description: Good critical overview of Sprout Pharma case, including data about substantial adverse events and limited efficacy. Very effective takedown on "fairness" rhetoric.
Author: Josh Bloom
Source: Science 2.0
URL: visit link

Title: The Drug that Cried "Feminism"
Date: 3/17/2015
Description: Powerful feminist arguments against flibanserin: it is "more like Spanish fly, or horny goat weed, or one of the other aphrodisiacs that have been disappointing humans for millennia." It's "sinister" to misappropriate feminist rhetoric. It's reactionary to try and eliminate "pesky government interference." And forget the "nebulous world of brain chemistry."
Author: Alessandra Hirsch, Rebecca Holliman, and Adriane Fugh-Berman
Source: The Hastings Center
URL: visit link

Title: Nothing is Wrong with your Sex Drive
Date: 2/27/2015
Description: Op-Ed focused on HSDD NOT being a disease because women often experience sexual desire as responsive, not spontaneous.
Author: Emily Nagoski
Source: New York Times
URL: visit link

1 to 88 of 88 records.